Shkreli Says His New Co. Doesn’t Violate FTC’s Pharma Ban

By Dorothy Atkins (February 10, 2023, 11:05 PM EST) — Convicted “Pharma Bro” Martin Shkreli opposed the Federal Trade Commission’s contempt motion accusing him of failing to comply with an order banning him from working in the pharmaceutical industry, arguing that his new company Druglike Inc. is a software business, not a pharmaceutical company….

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

• Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
• Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
• Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

No Byline Policy

Editorial Guidelines

Corrections Policy

Source